Financial statements Katomedica
Balance sheet data of KATOMEDICA
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 471 475,16 | 4 208 271,95 | 6 164 666,07 | 11 958 479,73 | 17 677 889,43 |
A. Fixed assets | - | 773 764,16 | 815 460,77 | 1 016 219,78 | 1 006 622,66 |
B. Current assets | 471 475,16 | 3 434 507,79 | 5 349 205,30 | 10 942 259,95 | 16 671 266,77 |
C. Share capital contributions (basic funds) | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - |
Total liabilities | 471 475,16 | 4 208 271,95 | 6 164 666,07 | 11 958 479,73 | 17 677 889,43 |
A. Equity | 201 791,59 | 3 481 155,34 | 4 777 621,02 | 7 352 595,60 | 8 442 373,19 |
B. Liabilities and provisions for liabilities | 269 683,57 | 727 116,61 | 1 387 045,05 | 4 605 884,13 | 9 235 516,24 |
I. Long-term liabilities | - | - | 276 991,90 | 0,00 | 0,00 |
II. Short-term liabilities | - | 727 116,61 | 1 110 053,15 | 4 605 884,13 | 9 235 516,24 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.